Charlotte’s Web To Sponsor Human Trial To Evaluate Whether Daily CBD Use Impacts The Liver
ValidCare is a clinical trial outsourcing company
Charlotte’s Web Holdings Inc. said Tuesday that it will sponsor ValidCare along with six other CBD brands in conducting a human trial to determine whether daily CBD use has any impact on the liver.
ValidCare is a clinical trial outsourcing company. In a statement, the Boulder, Colorado-based company said the study is a response to Food and Drug Administration’s public questions about CBD products and how they impact the human liver. “As the market share leader, anchored in science, sponsoring ValidCare’s study made strategic sense for us,” Chief Executive Deanie Elsner said in a statement. “This research will provide important clinical data to guide our entire industry while also showing the FDA we’ve heard their requests and are answering their questions with precise data.”
To Read The Rest Of This Article On Market Watch, Click Here
